openPR Logo
Press release

Biopharmaceutical Contract Manufacturing Market – Current Scenario and Future Growth Analysis by 2025

03-14-2018 10:53 AM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Biopharmaceutical Contract Manufacturing Market – Current

Contract manufacturing organizations (CMOs) are companies that offer a broad spectrum of services ranging from drug development to drug manufacturing on contract basis to the pharmaceutical companies. Biopharmaceutical contract manufacturing involves the development and manufacture of biopharmaceutical molecules for biopharmaceutical companies. Biopharmaceuticals include pharmaceutical products such as proteins, nucleic acids, blood components, and vaccines developed from biological sources.

The biopharmaceutical contract manufacturing market is anticipated to expand robustly during the forecast period. Strong growth of the market can be attributed to the risk hedging nature of biopharmaceutical companies by outsourcing manufacturing to CMOs. This enables biopharmaceutical companies to balance their risk and buy time until key clinical trial milestones are met. Additionally, lack of manufacturing capabilities and high investments required in R&D of biopharmaceuticals induce new market entrants to outsource manufacturing activities.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34412

Moreover, strong technical capabilities of the CMOs in cell-line development, scale-up, and process development, and rich pipeline of biologics such as viral vectors, multispecific monoclonal antibodies, peptides, and other oligonucleotides drive the biopharmaceutical contract manufacturing market. However, lack of capacity of CMOs to manufacture large-volume biopharmaceutical drug substances, complexity in transferring biological components, and limited options available for biopharmaceutical companies for large-volume production are projected to hamper the growth of the market.

The global biopharmaceutical contract manufacturing market can be segmented based on product type, platform, application, therapeutic area, services, and region. In terms of product type, the market can be classified into interferons, monoclonal antibodies, vaccines, recombinant hormones, growth factors, and others. Based on platform, the global biopharmaceutical contract manufacturing market can be categorized into mammalian and microbial. In terms of application, the market can be bifurcated into commercial and clinical.

Based on therapeutic area, the global biopharmaceutical contract manufacturing market can be segmented into oncology, cardiovascular diseases, metabolic disorders, neurology, respiratory diseases, hematology, autoimmune diseases, and others. In terms of services, the market can be bifurcated into manufacturing and research. The manufacturing services segment can be further divided into bulk drugs and active pharmaceutical ingredient (API) manufacturing, packaging, advanced drug delivery formulations, and finished dose formulations.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=34412

Geographically, the global biopharmaceutical contract manufacturing market can be segmented into five regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America accounted for the largest share of the global biopharmaceutical contract manufacturing market in terms of revenue in 2016. The trend is anticipated to continue during the forecast period. However, the market in Asia Pacific is anticipated to expand at a significant pace during the forecast period.

Rise in investments by contract manufacturing organizations in the region, increase in the number of companies outsourcing manufacturing activities to CMOs, and business and regulatory reforms contribute to the growth of the market. For instance, in August 2017, Fujifilm Holdings announced expansion of its biopharmaceutical contract manufacturer business by doubling the capacity of culture tanks by 2019. Growth of the market in Asia Pacific is anticipated to be driven by India and China. Focus on the development of biologics pipelines by domestic companies in China and rise in adoption of newer technology platforms such as single-use technologies by CMOs have been contributing to the growth of the market in the country.

Leading players operating in the global biopharmaceutical contract manufacturing market are Lonza Group, Samsung Biologics Co., Ltd., Rentschler Biotechnologie GmbH, Catalent, Inc., Fujifilm Diosynth Biotechnologies, Patheon N.V., Abzena plc, Ajinomoto Althea, Inc., Vetter Pharma International GmbH, WuXi Biologics, Boehringer Ingelheim GmbH, Pfizer CentreOne (contract manufacturing unit of Pfizer, Inc.,), and Cytovance Biologics, Inc., among others.

Obtain Report Details @ https://www.transparencymarketresearch.com/biopharmaceutical-contract-manufacturing-market.html

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biopharmaceutical Contract Manufacturing Market – Current Scenario and Future Growth Analysis by 2025 here

News-ID: 978025 • Views: 135

More Releases from Transparency Market Research

Market Intelligence Report on Calcite Market, 2018-2028
Sales of calcite have witnessed utter proliferation in recent time, in line with the growing demand from paper and pulp sector wherein calcite is highly adopted as a coating and filler material. According to Transparency Market Research analysis, global calcite market is anticipated to register 4.7% CAGR during the study period 2018–2028. The TMR report opines that demand for calcite is highly driven by its significant properties that are paving way
Pearlescent Pigments Market Intelligence Report Offers Growth Prospects
The demand within the global pearlescent pigment market is slated to rise as new creative avenues emerge in the art and craft industry. Several artists have increased the consumption of pearlescent pigments, mainly due to the aesthetic value of these pigments in art forms. The use of these pigments can majorly be attributed to the gloss and shine imparted by these pigments to the design or craft. These pigments exhibit
Aragonite Market to Witness Steady Growth During the Forecast Period 2018-2026
Global Aragonite Market: Overview Aragonite is a carbonate mineral having an orthorhombic crystal system, and very closely resembles calcite. It is considered as the purest form of calcium carbonate. The mineral has garnered wide popularity as gemstone in various parts of the world and has promising healing properties with energy enhancing powers. Aragonite contains traces of magnesium and sand inclusion but rich in calcium carbonate, and is alkaline in nature. It
OEM Insulation Market Growth, Trends and Value Chain 2019-2027 by TMR
OEM Insulation Market – Overview OEM means Original Equipment Manufacturer that indicates to a company that produces a part or a subsystem of a product that is being used by another organization. Thermal insulation or simply insulation allows the product to cut down the heat gain or loss at the minimum by creating a barrier between the surfaces at the varying temperatures. There are wide range of applications and end-use verticals

All 5 Releases


More Releases for CMOs

Global CMOS Sensor Market Insights, Forecast
The CMOS Sensor market was valued at Million US$ in 2017 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for CMOS Sensor Get sample copy of the report: https://www.marketdensity.com/contact?ref=Sample&reportid=49874 Table of Contents: Table of Contents 1 Study Coverage 1.1
CMOS Camera Lens Market Outlook 2022:Analysis By Type(Ordinary CMOS Camera Lens, …
CMOS Camera Lens Market Overview Brief Description:Miniature CCD/CMOS lenses are designed to provide optimal image performance for a variety of applications using CCD/CMOS imaging sensors. Typical consumer product applications include: digital cameras, PC cameras, cell phone and PDA cameras, security cameras, etc The Global CMOS Camera Lens Market skilled Survey Report scrutinizes the prevailing state of affairs and also the destiny growth potentialities of the business. It covers the market place
Global CMOS Image Sensor Market 2017-2021
key players in the global CMOS image sensor market: Sony, Samsung, OmniVision Technologies, and ON Semiconductor Other Prominent Vendors in the market are: Canon, GalaxyCore, Nikon, PixArt Imaging, PIXELPLUS, STMicroelectronics, and Toshiba. PDF sample download @ https://marketreportscenter.com/reports/557825/global-cmos-image-sensor-market-2017-2021# Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Amalgamation of CMOS and CCD sensors. In the camera industry, there is a high demand for image
CMOS Image Sensor Market to Perceive Substantial Growth by 2021
Some of the major players of the market include Samsung Group, Hitachi Ltd, Sony Corporation, Canon Inc, Olympus Corporation, Karl Storz GmbH and Co. Kg, PhotonFocus Ag, True Sense Imaging Inc., Espros Photonics Corporation, Fujifilm Holding Corporation, Nikon Corporation, CMOSIS and Teledyne Dalsa Inc. among others. Companies are continuously making efforts in providing latest technology related to CMOS image sensors. Samsung is providing these sensors with wide range of
Global CMOS Image Transducers Market Research Report Forecast 2017-2021
The Global CMOS Image Transducers Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the CMOS Image Transducers industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This CMOS Image Transducers market study provides comprehensive data which enhances the
CMOS HDTV Image sensors for highest applications
May 2011 High speed sensor for 3D-metrology With the new global shutter HDTV sensors 9221/2 and 9225/6 viimagic GmbH offers a high performance CMOS sensor for highest quality applications. Thanks to the high dynamic range the sensor can be used for optical metrology and 3D-measurement such as non-contacting three-dimensional shape measurement. In surveying and engineering work it is used for measuring triangulation networks. The new feature-rich 2 Megapixel sensors in 2/3”